Cancer

Attitudes to what men should be told before undergoing a PSA test were examined

Chris Degeling PhD, BVSc · Lucie Rychetnik PhD, MPH · Kristen Pickles MPH · Rae Thomas PhD · Jennifer A Doust BM BS, PhD, FRACGP · Robert A Gardiner MD, FRCS, FRACS · Paul Glasziou BM BS, PhD, FRACGP · Ainsley J Newson PhD, LLB(Hons), BSc(Hons) · Stacy M Carter PhD, MPH(Hons)

Despite ongoing progress in basic and preclinical cancer nanomedicine research, arguably the single most important challenge is clinical translation

Zdenka Kuncic FAIP, PhD, BSc(Hons)

How can we help our patients make sensible decisions?

Ian E Haines MB BS, FRACP, FAChPM

Implementation of precision medicine requires a multidisciplinary and systematic approach

Ingrid Winship MD, FRACP, FACD

Some high-burden areas of disease fall short in research efforts

Jacquelyne Lam MPharm, BSc · Sarah J Lord MB BS, MS, FRACGP · Kylie E Hunter BA(Human Movement)(Hons), BA(Indonesian) · R John Simes MB BS(Hons), MD, FRACP · Thuyen Vu BSc · Lisa M Askie PhD, MPH, BN

While vemurafenib induces ultraviolet A photosensitivity, it is important to consider alternative diagnoses when minimal response to therapy is attained

Rachael Anforth BMed · Giuliana Carlos MB BS · Noemi Eiris MB BS · Arthur Clements BSc(Med), MB BS, FRACP · Pablo Fernandez-Peñas MD, PhD, FACD

Clinical research embedded in cancer treatment centres improves both outcomes and cure rates at minimal cost

Catherine H Cole MB BS, FRACP, FRCPA

Australian research advances technique that may make prostate cancer screening less invasive and more accurate

Jeremy P Grummet MB BS, MS, FRACS · Richard O’Sullivan BSc, MB BS, FRANZCR

Diabetic ketoacidosis in patients with type 2 diabetes can indicate primary pancreatic disease

George Zhong MB BS(Hons), BSc(Hons) · Rosalba Cross FCICM, MB BS, BSc(Hons)

Ian Olver considers his time at Cancer Council Australia and suggests embracing cancer treatment, prevention and research provides a comprehensive cancer control experience

Ian N Olver MB BS, MD, PhD

The many benefits for rural doctors and patients suggest it is time for telehealth to be part of routine clinical practice

Sabe Sabesan BM BS, FRACP · Jenny Kelly BN, MPH, PhD

General practice needs to be the pivot in the national screening program

Oliver R Frank PhD, FRACGP, FACHI · Nigel P Stocks DipPH, MD, FRACGP

Investigating the spread of cancer by cancer type among Aboriginal and non-Aboriginal people in NSW

Alison Gibberd MStat · Rajah Supramaniam BSc, MPH(Hons) · Anthony Dillon PhD · Bruce K Armstrong DPhil, FRACP, FAFPHM · Dianne L O’Connell BMaths(Hons), PhD

The pressing matters now are maximising outcomes, recruiting to clinical trials and being able to afford these drugs

Georgina V Long PhD, MB BS, FRACP

A more flexible approach than that currently mandated by the PBS is recommended

Craig Gedye MB ChB, FRACP, PhD · Frances M Boyle MB BS, PhD, FRACP

Limited use of aggressive treatment, but late referrals to palliative care and high numbers dying in acute hospitals after lengthy stays

Jennifer Philip PhD, FAChPM, MMed · Peter Hudson PhD, BN(Hons), DipAppSc · Adam Bostanci PhD, MPhil, MSc · Annette Street BEd(Hons), PhD · Dell E Horey PhD, MMedSc(ClinEpidemiol), BAppSc · Sanchia Aranda PhD, MN · Rachel Zordan PhD, BSc(Psych), BSc(Health) · Bruce D Rumbold PhD, MA, MSc · Gaye Moore PhD, MPD, BN(Hons) · Vijaya Sundararajan MD, MPH, FACP

Peer review of multidisciplinary teams can improve cancer care, but needs fine-tuning

Neli S Slavova-Azmanova MD, PhD · Claire E Johnson PhD · Cameron Platell MB BS, PhD, FRACS · Sean Bydder MB ChB, MBA, FRANZCR · Christobel M Saunders MB BS, FRCS, FRACS

Advanced age should not be the major factor in considering a patient for curative radiotherapy

Richard C Khor BMedSc, MB BS, FRANZCR · Mathias Bressel BSc, MSc · Jo Tedesco MBIT · Keen Hun Tai MB BS, FRANZCR · David L Ball MB BS, MD, FRANZCR · Gillian M Duchesne MB ChB, MD, FRANZCR · Helen Farrugia BAppSc(HIM), GradDip(BIT) · Wai Kuan Yip PhD, GradDipAppStats · Farshad Foroudi MB BS, MPA, FRANZCR

There must be a balanced investment portfolio in cancer control

David C Currow MPH, PhD, FRACP · Sanchia Aranda PhD, RN, GAICD

The benefits of sentinel lymph node biopsy are unproven

Samuel S Zagarella MB BS(Hons), FACD · Michael Sladden MB ChB, MRCP, FACD · Catalin Popescu MD, PhD · Michael Bigby MD

An example of how boycotting the system can achieve result

Robert J Davies MB BS, FRACS

Does screening reduce the risk of developing colorectal cancer?

Annika Steffen MSc(Epid), PhD · Marianne F Weber BA(Hons), PhD · David M Roder BDS, MPH, DDSc(Epid) · Emily Banks MB BS, PhD, FAFPHM

Skin reviews, sun protection advice and caution in patients with previous SCC are recommended

Chin Fen Neoh BPharm, MPharm(ClinPharm), PhD · Gregory I Snell MB BS, FRACP, MD · Bronwyn Levvey RN, BEdStu, GradDipClinEpi · Tom Kotsimbos MD, FRACP · Orla Morrissey MB BCh, FRACP, PhD · Monica A Slavin MB BS, FRACP, MD · Kay Stewart BPharm, PhD · David C M Kong BPharm, MPharm, PhD

Excess deaths from cancer remain attributable to area of residence and socioeconomic status

Robyn Godding